BSF ENTERPRISE PLC

Share Issue/Capital Change • Dec 27, 2024

National Storage Mechanism | Additional information

RNS Number : 3498R

BSF Enterprise PLC

27 December 2024

27 December 2024

BSF Enterprise PLC

Admission of Placing Shares

Further to the announcement published on 4 December 2024, B SF Enterprise PLC ("BSF" or the "Company"), a leading innovator in tissue-engineered materials , has made an application to admit a total of 20,000,000 new ordinary shares ("Placing Shares") to the Official List of the FCA and to the Main Market of the London Stock Exchange. It is expected that settlement for the Placing Shares and Admission will become effective at 8am on 27 December 2024, and that dealings in the Placing Shares will commence at that time.

Following Admission, the total number of ordinary shares and voting rights in the Company will be 123,335,937. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

-Ends-

For further enquiries, please visit   www.bsfenterprise.com   or contact:

BSF Enterprise PLC
Geoff Baker - Executive Director Che Connon - CEO & Director
Shard Capital (Broker)
Damon Heath	0207 186 9000
Isabella Pierre	0207 186 9927

About BSF Enterprise PLC

BSF Enterprise PLC (BSF) develops and commercialises cutting-edge tissue-engineered solutions, including lab-grown leather, cultivated meat, and corneal repair technologies. By leveraging its proprietary scaffold-free platform, BSF aims to deliver sustainable alternatives to traditional materials and meet global demand for environmentally responsible innovations.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ALSBQLFLZLLFFBK